OmnicellMEX:OMCL 65 EV-to-FCF is 18.17 as of Jul. 02, 2026, which is 51% below its 10-year median of 37.05. GuruFocus rates MEX:OMCL with a GF Score™ of 65/100 and a GF Value™ of MXN703.76 (Fairly Valued). The stock has 6 warning signs investors should review. Among 406 Healthcare Providers & Services companies, Omnicell ranks worse than 54.68% on this metric.
EV-to-FCF is calculated as enterprise value divided by its free cash flow. As of today, Omnicell's Enterprise Value is MXN32,506 Mil.
Omnicell's Free Cash Flow for the trailing twelve months (TTM) ended in Mar. 2026 was MXN1,789 Mil. Therefore, Omnicell's EV-to-FCF for today is 18.17.
The historical rank and industry rank for Omnicell's EV-to-FCF or its related term are showing as below:
MEX:OMCL'
s EV-to-FCF Range Over the Past 10 Years
Min: -950.77 Med: 37.05 Max: 395.14
Current: 18.96
During the past 13 years, the highest EV-to-FCF of Omnicell was 395.14. The lowest was -950.77. And the median was 37.05.
MEX:OMCL's EV-to-FCF is ranked worse than 54.68% of 406
companies
in the Healthcare Providers & Services industry
Industry Median: 17.57
vs MEX:OMCL: 18.96
EV-to-FCF is a valuation multiple that allows analysts and investors to compare stocks, preferably in the same sector or industry. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio (TTM) to determine the fair market value of a company.
EV-to-FCF is a valuation multiple that allows analysts and investors to compare stocks, preferably in the same sector or industry. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio (TTM) to determine the fair market value of a company.
Omnicell's share price for today is MXN761.16.
Omnicell's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was MXN8.038.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Enterprise Value is used because it is a more complete measure in reflecting how much an investor pays when buying a company. Free Cash Flow is an important financial metric because it represents the actual amount of cash at a company's disposal. Companies with a low EV-to-FCF ratio, combined with a strong balance sheet are generally considered as undervalued.
Omnicell EV-to-FCF Related Terms
Omnicell EV-to-FCF Historical Data
* Premium members only.
The historical data trend for Omnicell's EV-to-FCF can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
MEX:OMCL vs TDOC, SDGR, OMDA: EV-to-FCF Comparison
For the Health Information Services subindustry, Omnicell's EV-to-FCF, along with its competitors' market caps and EV-to-FCF data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Omnicell EV-to-FCF vs Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, Omnicell's EV-to-FCF distribution charts can be found below:
* The bar in red indicates where Omnicell's EV-to-FCF falls into.
Omnicell's current Enterprise Value is MXN32,506 Mil.
Omnicell's Free Cash Flow for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was MXN1,789 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Omnicell (MEX:OMCL) has a EV-to-FCF of 18.17 as of Jul. 02, 2026. EV to FCF ratio is the company's enterprise value divided by free cash flow. View historical data on Omnicell and its competitors. This is 51% below median its historical median of 37.05. According to the industry distribution chart, Omnicell ranks #222 out of 406 companies in the Healthcare Providers & Services industry, placing it in the top 54.7%.
Is Omnicell's EV-to-FCF too high?
Omnicell's current EV-to-FCF of 18.17 is 51% below median its 10-year median of 37.05. The Healthcare Providers & Services industry median EV-to-FCF is 17.57. Omnicell's value of 18.17 is 3.4% above this industry median. Based on the distribution chart, Omnicell ranks #222 out of 406 companies in the Healthcare Providers & Services industry, which is below the industry midpoint. Overall, Omnicell has a GF Score™ of 65/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does Omnicell's EV-to-FCF compare to TDOC and SDGR?
According to the Healthcare Providers & Services industry distribution chart, Omnicell ranks #222 out of 406 companies for EV-to-FCF. This places Omnicell in the lower half of its industry. The industry median EV-to-FCF is 17.57. Omnicell's value of 18.17 is 3.4% above this benchmark. While the company's 10-year median is 37.05 vs. the industry median of 17.57, Omnicell has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EV-to-FCF for a Healthcare Providers & Services company?
The median EV-to-FCF among Healthcare Providers & Services companies is 17.57, based on 406 companies in the industry. Companies in the top quartile (top 25%) have a EV-to-FCF significantly above this median, while those in the bottom quartile fall well below. However, EV-to-FCF should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Omnicell's current EV-to-FCF of 18.17 is 3.4% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EV-to-FCF mean?
A high EV-to-FCF can signal that a stock is expensive relative to its fundamentals. EV to FCF ratio is the company's enterprise value divided by free cash flow. View historical data on Omnicell and its competitors. For the Healthcare Providers & Services industry, the median EV-to-FCF is 17.57 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Omnicell's current EV-to-FCF is 18.17, which is 51% below median its own 10-year median of 37.05. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Omnicell stock overvalued right now?
Based on GuruFocus' analysis, Omnicell (MEX:OMCL) is currently considered Fairly Valued. The stock's GF Value™ is MXN703.76, compared to a current price of MXN761.16 — trading 8.2% above its estimated fair value. The current EV-to-FCF is 18.17, which is 51% below median its 10-year median of 37.05 and 3.4% above the Healthcare Providers & Services industry median of 17.57. Omnicell's overall GF Score™ is 65/100 with 6 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EV-to-FCF calculated?
EV-to-FCF is calculated from a company's financial statements. For Omnicell (MEX:OMCL), the current EV-to-FCF is 18.17 as of Jul. 02, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Omnicell (MEX:OMCL) Overvalued in 2026?
Based on GuruFocus' analysis, Omnicell stock appears to be overvalued.
The current stock price of MXN761.16 is trading 8.2% above its estimated GF Value™ of MXN703.76.
GuruFocus considers Omnicell to be Fairly Valued.
Key valuation signals for MEX:OMCL:
EV-to-FCF: 18.17 (51% below median its 10-year median of 37.05)
GF Value™: MXN703.76 vs. price of MXN761.16 (8.2% above fair value)
Industry Position: 3.4% above the Healthcare Providers & Services median (#222 of 406)
No single metric tells the full story. See the MEX:OMCL stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Omnicell Inc provides automation and business analytics software for healthcare providers. The company is engaged in transforming the pharmacy and nursing care delivery model. The company helps its customers define and deliver cost-effective medication management designed to equip and empower pharmacists and nurses to focus on patient care rather than administrative tasks and drive improved clinical, operational, and financial outcomes across all care settings. The company derives the majority of its revenue from the United States.
65GF Score
Get the complete analysis for MEX:OMCL
EV-to-FCF is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
MEX:OMCL has been successfully added to your 
